The efficacy of platinum-based chemotherapy for immune checkpoint inhibitor-resistant advanced melanoma

Authors

  • Takuya Maeda Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
  • Koji Yoshino Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
  • Kojiro Nagai Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
  • Satoe Oaku Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
  • Megumi Kato Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
  • Azusa Hiura Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
  • Hiroo Hata Department of Dermatology, Faculty of Medicine and Graduate School of Medicine Hokkaido University, Sapporo, Japan

DOI:

https://doi.org/10.1080/0284186X.2018.1541252

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2019-03-04

How to Cite

Maeda, T. ., Yoshino, K. ., Nagai, K. ., Oaku, S. ., Kato, M. ., Hiura, A. ., & Hata, H. . (2019). The efficacy of platinum-based chemotherapy for immune checkpoint inhibitor-resistant advanced melanoma. Acta Oncologica, 58(3), 379–381. https://doi.org/10.1080/0284186X.2018.1541252

Issue

Vol. 58 No. 3 (2019): Acta Oncologica

Section

Articles